BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...

Is obesity a disease or a risk factor for disease? In medical circles – and outside of them – the question is contentious, ...

11 Marketing Plan Templates You Can (Legally) Steal for Free Your email has been sent A marketing plan defines key objectives and ensures your campaigns tie in to big-picture objectives.

The free plan is great for personal use, but the platform can also accommodate collaborative goals on a team or company-wide level. ClickUp offers goal-setting templates for daily goals and quick ...

It takes a realistic and practical approach which acknowledges that the solutions to tackling overweight and obesity are many, that even small steps can add up to a big result and that every sector ...

Meanwhile, Eli Lilly’s Zepbound, approved in 2023, and its diabetes drug Mounjaro, also used off-label for weight loss, have joined the ranks of high-demand therapies for obesity care. While the new ...

In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

Obesity continues to plague New Yorkers ... But at a time when we should be promoting health care access, the health plan for New York City employees recently made a surprising decision with ...

LONDON/COPENHAGEN, Dec 20 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug ...

The numbers showed that both average body mass index (BMI) and obesity rates across the population fell in 2023, having risen steadily since 2013 before leveling in 2022. While we don't yet have any ...

A new type of obesity drug being developed by Novo Nordisk has fallen short of expectations set by the company in a closely watched Phase 3 trial, causing shares to lose nearly a fifth of their value ...

Speaker Mike Johnson (R-La.) is looking at a plan B to fund the government ahead of Friday’s shutdown deadline as Republicans inside and outside the Capitol, including President-elect Trump and ...